Insulet Corp. (PODD)

292.82 -6.35 (-2.12%) USD  |  NASDAQ  |  Jan 08, 16:00
292.82 0.00 (0.00%) After-Hours: 20:00
More

Insulet Research and Development Expense (Quarterly): 77.20M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for PODD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Tandem Diabetes Care, Inc. 47.88M
Boston Scientific Corp. 514.00M
Intuitive Surgical, Inc. 329.40M
Abbott Laboratories 748.00M
Globus Medical, Inc. 38.07M